Ezetimibe promotes CYP7A1 and modulates PPARs as a compensatory mechanism in LDL receptor-deficient hamsters
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ezetimibe promotes CYP7A1 and modulates PPARs as a compensatory mechanism in LDL receptor-deficient hamsters
Authors
Keywords
-
Journal
Lipids in Health and Disease
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-08
DOI
10.1186/s12944-020-1202-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HDL and Reverse Cholesterol Transport
- (2019) Mireille Ouimet et al. CIRCULATION RESEARCH
- Fucoidan A2 from the Brown Seaweed Ascophyllum nodosum Lowers Lipid by Improving Reverse Cholesterol Transport in C57BL/6J Mice Fed a High-Fat Diet
- (2019) Zixun Yang et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Dietary Cholesterol Is Highly Associated with Severity of Hyperlipidemia and Atherosclerotic Lesions in Heterozygous LDLR-Deficient Hamsters
- (2019) Jinjie Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Association Between Low‐Density Lipoprotein Cholesterol and Incident Atherosclerotic Cardiovascular Disease in Older Adults: Results From the National Institutes of Health Pooled Cohorts
- (2019) Michael G. Nanna et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Current Understanding and Future Perspectives
- (2019) M. F. Wu et al. CARDIOVASCULAR DRUGS AND THERAPY
- LDL Receptor Gene-ablated Hamsters: A Rodent Model of Familial Hypercholesterolemia With Dominant Inheritance and Diet-induced Coronary Atherosclerosis
- (2018) Xin Guo et al. EBioMedicine
- Cholesterol transport system: An integrated cholesterol transport model involved in atherosclerosis
- (2018) Xiao-Hua Yu et al. PROGRESS IN LIPID RESEARCH
- Exogenous supplement of N-acetylneuraminic acid ameliorates atherosclerosis in apolipoprotein E-deficient mice
- (2016) Shoudong Guo et al. ATHEROSCLEROSIS
- Transintestinal Cholesterol Transport Is Active in Mice and Humans and Controls Ezetimibe-Induced Fecal Neutral Sterol Excretion
- (2016) Lily Jakulj et al. Cell Metabolism
- The combination of ezetimibe and ursodiol promotes fecal sterol excretion and reveals a G5G8-independent pathway for cholesterol elimination
- (2015) Yuhuan Wang et al. JOURNAL OF LIPID RESEARCH
- Microbiota prevents cholesterol loss from the body by regulating host gene expression in mice
- (2015) Chun-Yan Zhong et al. Scientific Reports
- Ezetimibe enhances macrophage reverse cholesterol transport in hamsters: Contribution of hepato–biliary pathway
- (2014) Harumi Uto-Kondo et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Liver-specific induction of Abcg5 and Abcg8 stimulates reverse cholesterol transport in response to ezetimibe treatment
- (2014) Jessica B. Altemus et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Ezetimibe Inhibits Hepatic Niemann-Pick C1-Like 1 to Facilitate Macrophage Reverse Cholesterol Transport in Mice
- (2013) Ping Xie et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans
- (2013) Michael H. Davidson et al. ATHEROSCLEROSIS
- Ezetimibe ameliorates intestinal chylomicron overproduction and improves glucose tolerance in a diet-induced hamster model of insulin resistance
- (2012) Mark Naples et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Biliary and nonbiliary contributions to reverse cholesterol transport
- (2012) Ryan E. Temel et al. CURRENT OPINION IN LIPIDOLOGY
- The ABCG5 ABCG8 sterol transporter and phytosterols: implications for cardiometabolic disease
- (2011) Nadezhda S Sabeva et al. Current Opinion in Endocrinology Diabetes and Obesity
- Biliary Sterol Secretion Is Not Required for Macrophage Reverse Cholesterol Transport
- (2010) Ryan E. Temel et al. Cell Metabolism
- Transintestinal cholesterol efflux
- (2010) Astrid E van der Velde et al. CURRENT OPINION IN LIPIDOLOGY
- Both the Peroxisome Proliferator-Activated Receptor δ Agonist, GW0742, and Ezetimibe Promote Reverse Cholesterol Transport in Mice by Reducing Intestinal Reabsorption of HDL-Derived Cholesterol
- (2009) François Briand et al. CTS-Clinical and Translational Science
- Inhibiting intestinal NPC1L1 activity prevents diet-induced increase in biliary cholesterol in Golden Syrian hamsters
- (2008) Mark A. Valasek et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Cholesterol Absorption From the Intestine Is a Major Determinant of Reverse Cholesterol Transport From Peripheral Tissue Macrophages
- (2008) Ephraim Sehayek et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Liver X receptor (LXR ): A link between -sitosterol and amyotrophic lateral sclerosis-Parkinson's dementia
- (2008) H.-J. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now